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ing author. Tel.: +44121
ess: srikumarmallick@hSummary Pulmonary embolism (PE) is the commonest cause of maternal death in
UK. It is a frequently occurring diagnostic challenge. The false negative and false
positive rates for the diagnosis of PE are spectacularly high. Undiagnosed PE has a
mortality rate as high as 30%, which falls to 2–8% if the condition is diagnosed and
treated appropriately. [Rodger M, Wells PS. Diagnosis of pulmonary embolism.
Thromb Res 2001;103:v225–38; Guidelines on Diagnosis and Management of Acute
Pulmonary Embolism. Task Force on Pulmonary Embolism, European Society of
Cardiology. Eur Heart J 2000;21(16):1301–36].
Physiologic changes of pregnancy further complicate the diagnosis of PE. Although
the danger of maternal and foetal death secondary to maternal PE and unnecessary
anticoagulation far outweighs the risk of radiation involved in scanning, doctors still
hesitate to request appropriate investigation because of concern regarding radiation
exposure to the foetus and the absence of any clear, updated guideline. Worried
parents need to be counselled appropriately before tests to alleviate anxiety and
misunderstanding.
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Pulmonary embolism (PE) remains the single major
direct cause of maternal death in the United
Kingdom (Table 1).1 The incidence of VTE is five
times higher in pregnant women than in age-
matched non-pregnant women. It was previously
thought that the risk of thromboembolism is high
during third trimester and immediately postpartum
but recent studies showed that VTE may occur with
almost equal frequency in all three trimesters.2 Age
over 30, obesity, multiparity, and caesarean section
increases the risk of thromboembolism.
Factors predisposing to venous thrombosis like
Stasis, hypercoagulability, and endothelial injury
(Virchow’s Triad) may develop during pregnancy
and the puerperium.
At term, flow velocity of the common femoral
vein slowed to less than one-third of the velocity
recorded in the first trimester and in the post-
partum period. Venous stasis of pregnancy is likely
related to compression of the common iliac vein by
the gravid uterus. Majority of the deep venous
thrombosis during pregnancy (about 80%) occurs in
the left leg because of compression of the left iliac
vein by the right iliac artery at its origin from the
aorta.2
Pregnancy is associated with decreased level of
protein S; elevated factors I, VII, VIII, and X; and
progressive resistance to protein C activity3 result-
ing in a state of hypercoagulability.
The trauma of operative delivery, previous DVT,
smoking all can cause endothelial damage during
pregnancy.4
Non-specific symptoms like dyspnoea, tachyp-
noea are quite common in pregnancy and easily
create diagnostic enigma for clinicians. The diag-
nosis of PE in pregnancy is difficult. The physiologic
changes of pregnancy further complicate interpre-Table 1 Causes of maternal direct deaths in
United Kingdom (rates per million).
1. Thrombosis and thromboembolism (15)
2. Haemorrhage (8.3)
3. Early pregnancy deaths (ectopics,
miscarriage, termination)
(7.3)
4. Hypertensive disease of pregnancy (7)
5. Amniotic fluid embolism (2.3)
6. Genital tract sepsis (5.3)
7. Others (trauma, fatty liver, etc.) (4.0)
8. Anaesthesia (3)
Adapted from Report on Confidential Enquiry into
Maternal Deaths in the United Kingdom. Department of
Health. (2).tation of the history, physical examination, and test
results.
Pregnant women normally had a compensated
respiratory alkalosis and a widened alveolar arter-
ial gradient. The minute ventilation increases
significantly, reaching 20–40% above the baseline
at term. This is the result of a raised tidal volume in
addition to the increased respiratory drive stimu-
lated by high serum progesterone level. Mild
hypoxemia might occur when the patient is in the
supine position, so arterial blood gas should be
taken either in sitting or standing position.Diagnosis
Clinical features: Several studies have shown that
dyspnoea plus tachypnoea (respiratory rate 420/
min) is present in 90% patients. Only 3% of patients
have neither of these nor pleuritic pain; the
reminder have either chest radiographic changes
or a low-PaO2. The absence of all these clinical
features virtually excludes the diagnosis of PE.5,6
Pregnancy itself is an independent risk factor for
PE, so all pregnant women start with an inter-
mediate risk when assessed by the BTS recom-
mended clinical risk assessment. In these cases
therefore Wells scoring is a preferred choice to
assess clinical probability.
D-dimmer level can be elevated during preg-
nancy. The D-dimer level increases progressively
during pregnancy (above the standard cut-off of
500 ng/mL). One study (among 50 patients) by
Hernandez et al.7 showed that the upper limits of
the 95% CI (rounded) for each trimester were 700,
1000, and 1420 ng/mL. For each trimester, 25% (95%
CI: 5–41%), 29% (11–43%), and 19% (5–41%) of
healthy women had D-dimer levels above these
cut-offs. Per trimester, 50%, 75%, and 100% of
D-dimer levels exceeded 500 ng/mL. Larger studies
are required to determine the threshold for
abnormal D-dimer in pregnant patients. D-dimer
measurement for ruling out VTE was found to be
useful again 4 weeks after delivery.8 From this
study we can conclude that it is still worth checking
D-dimer in the initial period, particularly in first
trimester, in low and intermediate clinical prob-
ability, where up to 50% of pregnant ladies without
VTE will have a negative test and can avoid an
unnecessary scan if suspected for PE.
Leg Ultra sound should be the initial investigation
in patients with clinical DVT. After 20 weeks
gestation it is more difficult to interpret for DVT
due to altered venous return associated with
venacaval compression by the uterus. More than
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left side.VQ scan or CTPA
Unfortunately, there are not enough trials evaluat-
ing the accuracy and safety of different diagnostic
tests in pregnant patients mainly due to concern
regarding exposure of the foetus to ionizing
radiation. Most of the data are extrapolated from
studies on non-pregnant population. The recent
BTS guidelines on PE have not thrown lights on this
aspect and the guidelines from royal college of
obstetrics and gynaecology is overdue for updating.
The choice for imaging depends on diagnostic
efficacy and minimization of foetal exposure to
ionizing radiation.
Efficacy: Most of the information regarding
ventilation-perfusion scanning comes from
PIOPED,9 a prospective multi-institutional effort,
which compared ventilation-perfusion scanning
with the standard diagnostic criterion of pulmonary
angiography. In this study, 34% of the scans were
low probability for VTE (of which 14% found to have
PE) and 39% were intermediate probability (of
which 30% found to have PE). It showed that more
than 60% of VQ scans are non-diagnostic where
additional diagnostic studies must be pursued,
since the probability of PE is still considerable.
This results in delay, further cost and more
radiation exposure which is not desirable in
pregnancy.
According to recent BTS guidelines CTPA is now
the recommended initial lung imaging modality for
non-massive PE. Patients with a good quality
negative CTPA do not require further investigation
or treatment for PE. CTPA (a) is quicker to perform,
(b) rarely needs to be followed by other imaging,
(c) may provide the correct diagnosis when PE has
been excluded, (d) is now available in most
hospitals, and (e) is easier to arrange urgently out
of hours.5
Although CTPA is not that accurate to detect
isolated small peripheral PEs compared to more
proximal emboli (sensitivity and specificity of more
than 90%), identification of isolated sub segmental
or chronic PE in a high proportion of patients is now
possible with the newer multi-detector CT scan-
ners. Winer Muram et al. showed in a study group
comprised 93 patients (median age, 56 years;
range, 19–88 years) sensitivity, specificity, and
accuracy of multi-detector CT were 100%, 89%,
and 91%, respectively, when compared with pul-
monary angiogram.10 A Recent study by Perrieret al.11 comprising of 756 patients revealed that
the incidence of proximal DVT despite negative
findings on multidetector CT is very low (0.9%, 95%
confidence interval, 0.3–2.7). Therefore, addition
of venous ultrasound improves the specificity only
marginally in this series. The three month throm-
boembolic risk in patients left untreated on the
basis of negative multidetector CT scan is 1.5%,
similar to pulmonary angiography and other recent
outcome studies.
The clinical significance of smaller PE is also
debatable. One study by Eyer et al. showed that
patients with isolated sub segmental PE who did not
receive anticoagulation, no recurrent PE was
identified on follow-up12 and in another study
comprising of 1512 patients Swensen et al. con-
cluded that the incidence of PE among patients
with suspected acute PE, negative CT results, and
no other evidence of venous thromboembolism is
low (0.5%). Withholding anticoagulation in these
patients appears to be safe.13 The importance of
small PE must be balanced against the risk of
anticoagulation, which includes a 1% fatality rate
and a 7% major complication rate per treatment
year.14 If still clinical suspicion for PE is very high
and patient remains symptomatic (hypoxic) addi-
tional test like serial lower extremity ultrasono-
graphy or pulmonary angiogram or repeat CTPA
should be considered. Local resources and exper-
tise should dictate study selection.15
Radiation exposure: The patient and her physi-
cian are usually concerned about potential harm to
the foetus from radiation exposure. The effects of
radiation on the fetus are radiation induced
teratogenesis, malignancies and genetic mutations.
For mental retardation and lowering of IQ the
threshold is perhaps 0.1–0.2 Gy and the most
sensitive period is 8–17 weeks of gestation.16 The
accepted cumulative dose of ionizing radiation
during pregnancy is 5 rad (0.05 gray or 50m gray
or 50mSv) and no single diagnostic study exceeds
this maximum. About 71,000 chest X-rays or 50
CTPAs or 30 VQ scans lead to a foetal radiation
exposure of 5 rad.17
Studies that estimated the dose that would be
received by each foetus from CT scanning reported
that the average foetal radiation dose with helical
CT is less than that with ventilation-perfusion lung
scanning during all trimesters.
In their study using Monte Carlo technique
Winer Muram et al. showed that for helical CT,
estimated mean fetal doses: 3.3–20.2 mGy, first
trimester; 7.9–76.7 mGy, second trimester; and
51.3–130.8 mGy, third trimester. These values were
all less than mean fetal doses reported with VQ
scan (100–370 mGy).18
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tic imaging methods (adapted from Kevin
et al., 1999; Toppenberg et al., 1999).17
Examination EFD (rad)
CXR (2 views) 0.00007
CT Head (10 sl) o0.050
CTPA o0.100
CT abdomen (10) o2.600
VQ scan 0.215
Perfusion scan 0.175
Ventilation scan 0.040
Environmental background radiation 0.100EFD-Estimated foetal dose.
Cost effectiveness: Doyle et al. in their study20
analyzed three different study design (1) leg ultra-
sound, (2) vq scan and (3) CTPA as the preliminary
test indicated that spiral computed tomography as
the initial investigation offers the most cost-effec-
tive method for diagnosing this potentially fatal
condition. (Spiral CT as the primary modality
$17,208 per life saved compared to compression
ultrasound strategy $24,004 per life saved and VQ
scan strategy $35,906 per life saved.)
Considering these data we can suggest that,
because of higher sensitivity and specificity and
relatively modest cost multi detector spiral CT is
the preferred diagnostic test for suspected PE in
pregnancy.
Counseling: When a radiological investigation is
planned for a pregnant lady, the most important
question arises is whether it is safe for the baby. In
routine diagnostic imaging the radiation doses
rarely reach the risk limits and therefore the risks
to the developing fetus are quite small. It is most
important that all expectant mother should be
counselled appropriately before the procedure if it
is necessary with clear explanation of the benefits
of the test. Statistics show that among the general
population, in 4–6% of all deliveries, some sponta-
neous malformation is present. The patient should
be explained about this beforehand because if after
any exposure an anomaly is found, a parent’s
natural inclination may be to blame radiation,
and it will then be difficult to help them understand
baseline malformation rates. Legal liability with
exposures less than 5 rad should be minimal.
No single diagnostic procedure results in a
radiation dose that threatens the well-being of
the developing embryo and fetus.-American College of Radiology
Diagnostic radiological procedures should not be
performed during pregnancy unless the informa-
tion to be gained from the study is necessary for
the care of the patient and cannot be deter-
mined by other means, especially sonography.
Risk to the mother: Although the radiation
exposure of the foetus is less in CTPA compared
to isotope lung scan the breast dose to the mother
from CTPA is much higher than from a perfusion
scan. Calculated dose to the breast tissue of an
average-sized woman during a CT pulmonary
angiography examination was at least 2.0 rad per
breast. There is a potential carcinogenic effect of
ionizing radiation on radiosensitive tissues such as
the female breast. Younger women are considered
to be more at risk of radiation induced breast
malignancy than the older screening population.
It is also of concern that the proliferating breast
in pregnancy is likely to be more radiosensitive.
One millisievert (mSv) of radiation exposure may be
associated with five additional cancers in 100,000
exposed patients. If we consider the baseline risk
that approximately 23% of the population will
develop cancer at some point in their lives, the
increased risk due to CT scanning is very small. Still
effort should be made to further reduce this very
small risk by proper selection of patients (exclusion
by D-dimmer and leg ultrasound where applicable).
Another study showed that thin-layered bismuth
breast shields may reduce breast radiation expo-
sure by 57% without greatly affecting diagnostic
interpretation.21 Perfusion scans may still be the
investigation of choice in those with low clinical
probability, free from previous cardio respiratory
disease but with a family history of breast cancer or
those who have had previous studies.Conclusion
Although PE is a leading cause of maternal
mortality doctors still hesitate to order appropriate
investigation. Mortality of untreated PE in preg-
nancy is as high as 30%. This drops to 2–8% with
therapy. The danger of maternal and foetal death
secondary to maternal PE and unnecessary antic-
oagulation far outweighs the risk of radiation
involved in scanning. Accurate diagnostic testing
is required to confirm PE, particularly in pregnancy
as it involves therapy with heparin throughout
pregnancy, prophylaxis during future pregnancy
and avoidance of oral contraceptive pills. D-dimer
(first trimester) and leg ultrasound (in case of
clinical DVT) can reduce the need for further scans
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weeks of gestation. CTPA has fewer non-diagnostic
results and lower foetal radiation dose than VQ
scan but it slightly increases the risk of breast
cancer in the mother which can be further reduced
if appropriate measures are taken.Summary points
 PE is the commonest cause of maternal
death in UK
 The danger of maternal and foetal death
secondary to maternal PE and unnecessary
anticoagulation far outweighs the risk of
radiation involved in scanning
 Undiagnosed PE has a mortality rate as high
as 30%, which falls to 2–8% if the condition
is diagnosed and treated appropriately
 Hypoxemia might occur when the patient is
in the supine position, so arterial blood gas
should be taken either in sitting or standing
position
 A total of 97% of patients with PE would
present either with dyspnoea, tachypnoea
or pleuritic chest pain
 Per trimester, 50%, 75%, and 100% of D-
dimer levels exceeded 500 ng/mL. D-dimer
measurement for ruling out VTE was found
to be useful again 4 weeks after delivery
 It is worth checking D-dimer in the initial
period, particularly in first trimester, where
up to 50% of pregnant ladies without VTE
will have a negative test and can avoid
an unnecessary scan if suspected for PE
and have low or intermediate clinical
probability
 Pick up rate of leg ultrasound in non-clinical
DVT and normal CTPA is low. It is more
difficult to interpret after 20 weeks of
gestation because of altered venous return
associated with venacaval compression by
the gravid uterus
 More than 60% of VQ scans are non-
diagnostic where additional diagnostic stu-
dies must be pursued, since the probability
of PE is still considerable. This results in
delay, further cost and more radiation
exposure, which is not desirable in preg-
nancy
 Because of higher sensitivity and specificity
and relatively modest cost multi-detector
spiral CT is the preferred diagnostic test for
suspected PE in pregnancy
 Average foetal radiation dose with
helical CT is less than that with ventila-tion-perfusion lung scanning during all
trimesters
 The accepted cumulative dose of ionizing
radiation during pregnancy is 5 rad, and No
single diagnostic study exceeds this max-
imum. About 71,000 chest X-rays or 50
CTPAs or 30 VQ scans lead to an foetal
radiation exposure of 5 rad. Legal liability
with exposures less than 5 rad should be
minimal
 Among the general population, in 4–6% of
all deliveries, some spontaneous malforma-
tion is present. Parents should be explained
about this baseline risk before the imaging
 Although the radiation exposure of the
foetus is less in CTPA compared to isotope
lung scan the breast dose to the mother
from CTPA is much higher than from a
perfusion scan. There is a potential carci-
nogenic effect of ionizing radiation on
radiosensitive tissues such as the female
breast
 Thin-layered bismuth breast shields may
reduce breast radiation exposure by
57% without greatly affecting diagnostic
interpretationReferences
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